Uniplan Investment Counsel, Inc. Harrow Health, Inc. Transaction History

Uniplan Investment Counsel, Inc.

$1.08 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$14.03 - $22.08 $66,446 - $104,570	4,736 Added 2.23%	216,934 $3.11 Million
Q2 2023 Aug 14, 2023	SELL	$17.37 - $28.08 $2 Million - $3.24 Million	-115,236 Reduced 35.19%	212,198 $4.04 Million
Q1 2023 May 15, 2023	SELL	$13.84 - $21.46 $2.13 Million - $3.31 Million	-154,184 Reduced 32.01%	327,434 $6.93 Million
Q4 2022 Feb 14, 2023	SELL	$10.28 - $14.78 $2.19 Million - $3.14 Million	-212,639 Reduced 30.63%	481,618 $7.11 Million
Q3 2022 Nov 14, 2022	SELL	$6.57 - $24.88 $41,916 - $158,734	-6,380 Reduced 0.91%	694,257 $8.38 Million
Q2 2022 Aug 15, 2022	BUY	$5.75 - $7.74 $1.1 Million - $1.48 Million	191,710 Added 37.67%	700,637 $5.1 Million
Q1 2022 May 16, 2022	BUY	$6.77 - $8.66 $25,543 - $32,674	3,773 Added 0.75%	508,927 $3.47 Million
Q4 2021 Feb 14, 2022	BUY	$8.5 - $12.0 $16,192 - $22,860	1,905 Added 0.38%	505,154 $4.36 Million
Q3 2021 Nov 15, 2021	SELL	$6.99 - $10.6 $30,427 - $46,141	-4,353 Reduced 0.86%	503,249 $4.57 Million
Q2 2021 Aug 13, 2021	BUY	$6.68 - $11.07 $43,313 - $71,777	6,484 Added 1.29%	507,602 $4.72 Million
Q1 2021 May 14, 2021	SELL	$6.26 - $11.03 $28,971 - $51,046	-4,628 Reduced 0.92%	501,118 $3.38 Million
Q4 2020 Feb 12, 2021	BUY	$4.76 - $6.93 $1.09 Million - $1.59 Million	229,239 Added 82.91%	505,746 $3.47 Million
Q3 2020 Nov 13, 2020	BUY	$4.71 - $7.36 $589,701 - $921,486	125,202 Added 82.75%	276,507 $1.55 Million
Q2 2020 Aug 14, 2020	SELL	$3.61 - $6.47 $13,649 - $24,463	-3,781 Reduced 2.44%	151,305 $788,000
Q1 2020 May 15, 2020	BUY	$3.5 - $7.31 $77,861 - $162,618	22,246 Added 16.75%	155,086 $592,000
Q4 2019 Feb 14, 2020	BUY	$4.6 - $7.88 $611,064 - $1.05 Million	132,840 New	132,840 $1.03 Million

Others Institutions Holding HROW

# of Institutions

174

Shares Held

21.2M

Call Options Held

844K

Put Options Held

698K

Opaleye Management Inc. Boston, MA

3.99M
Shares

$126 Million
32.75% of portfolio
Private Capital Management, LLC Naples, FL

2.16M
Shares

$68.3 Million
11.41% of portfolio
Black Rock Inc. New York, NY

2.15M
Shares

$67.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.87M
Shares

$58.9 Million
0.0% of portfolio
State Street Corp Boston, MA

731K
Shares

$23.1 Million
0.0% of portfolio

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $854M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Uniplan Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Uniplan Investment Counsel, Inc. with notifications on news.

Account